Illumina Files 8-K for Regulation FD Disclosure

TL;DR

Illumina dropped an 8-K, likely a Reg FD disclosure. Check for news.

AI Summary

On April 12, 2024, Illumina, Inc. filed an 8-K report. The filing primarily concerns a Regulation FD Disclosure, indicating that the company is providing material information to the public. No specific financial transactions or material events beyond this disclosure are detailed in the provided text.

Why It Matters

This filing signifies that Illumina is making a public disclosure of information, which could be material to investors. Investors should review the full filing for details on the nature of the disclosure.

Risk Assessment

Risk Level: low — The filing is a standard regulatory disclosure and does not, in itself, indicate any immediate financial or operational risks.

Key Players & Entities

• Illumina, Inc. (company) — Registrant
• April 12, 2024 (date) — Date of earliest event reported

FAQ

From the Filing

0001110803-24-000013.txt : 20240412 0001110803-24-000013.hdr.sgml : 20240412 20240412090114 ACCESSION NUMBER: 0001110803-24-000013 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20240412 ITEM INFORMATION: Regulation FD Disclosure FILED AS OF DATE: 20240412 DATE AS OF CHANGE: 20240412 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ILLUMINA, INC. CENTRAL INDEX KEY: 0001110803 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 330804655 STATE OF INCORPORATION: DE FISCAL YEAR END: 1229 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35406 FILM NUMBER: 24840100 BUSINESS ADDRESS: STREET 1: 5200 ILLUMINA WAY CITY: SAN DIEGO STATE: CA ZIP: 92122 BUSINESS PHONE: 8582024500 MAIL ADDRESS: STREET 1: 5200 ILLUMINA WAY CITY: SAN DIEGO STATE: CA ZIP: 92122 FORMER COMPANY: FORMER CONFORMED NAME: ILLUMINA INC DATE OF NAME CHANGE: 20000331 8-K 1 ilmn-20240412.htm 8-K ilmn-20240412 0001110803 FALSE 0001110803 2024-04-12 2024-04-12 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form  8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 12, 2024 Illumina, Inc. (Exact name of registrant as specified in its charter) 001-35406 (Commission File Number) Delaware   33-0804655 (State or other jurisdiction of incorporation)   (I.R.S. Employer Identification No.) 5200 Illumina Way , San Diego , CA 92122 (Address of principal executive offices) (Zip code) ( 858 )  202-4500 (Registrant’s telephone number, including area code) N/A (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐      Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐      Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐      Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.01 par value ILMN The NASDAQ Global Select Market Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐      If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13a of the Exchange Act. o      Item 7.01 Regulation FD Disclosure Illumina, Inc. (the "Company") was notified today that the European Commission (the "EC") has formally approved the Company's divestment plan with respect to GRAIL, LLC (the "Divestment Plan"), which had been submitted to the EC pursuant to the EC's October 12, 2023, divestment order. Pursuant to the Divestment Plan, the Company may continue to concurrently explore both a trade sale and a capital markets divestiture. In the instance of a capital markets transaction, Illumina must capitalize GRAIL at the time of transaction with two-and-a-half years of funding based on GRAIL's long-range plan. The Company expects the amount of such funding will be approx